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KIDNEY transplantation has improved tremendouslyover the past decades. After the introduction of
cyclosporine (CyA), delayed graft function and surgical
complications became the most important prognostic fac-
tors.1 Early diagnosis and management can save the grafted
kidney and prevent life-threatening complications.2–4 We
investigated the surgical complications in 1000 kidney trans-
plantations at our center.
PATIENTS AND METHODS
From June 1980 to February 2001, a total of 1000 kidney trans-
plantations were performed in our department. In 985 cases, the
kidney came from a cadaveric donor; in the remaining 15 cases, it
came from a living-related donor. The average age of the recipients
was 40.7 years and male:female patient ratio was 663:337. From
1980 to 1985, the immunosuppressive protocol included prednisone
and azathioprine with low-dose CyA added to patients treated after
1985. From 1980 to 1987, ureteroneocystotomy was mainly per-
formed using a modified Politano-Leadbetter technique. Since
then, we have adopted the extra-vesical Lich-Gregoir technique
with temporary ureteral stenting. For the majority of the proce-
dures (84.1%), we have used the common iliac artery for an
end-to-side arterial anastomosis. Surgical complications occurring
at any time after transplantation were recorded, as all transplant
patients continued to be followed at our institution except in the
case of graft loss or death. All patients in the series were followed
for at least a year. The list of complications included urological,
vascular, lymphatic, and wound-related problems.
RESULTS
There were 154 (15.4%) postoperative surgical complica-
tions. The urological complications were as follows: urinary
obstruction in 31 (3.1%) patients, ureteral fistulae in 25
(2.5%), and distal ureteral necrosis in 4 (0.4%). There were
2 (0.2%) vesical ruptures, 1 calcification of the stent, and 1
broken stent after traction. Twenty-four of the 25 fistulae
occurred within 4 weeks after transplantation, while the
interval to onset of obstruction ranged from 10 days to 11
years. Obstructions were cured by open surgery in 23 cases,
by endoscopic incision in 4 cases, and by temporary stenting
in 4 others. Among the patients with urinary leakage, 23
were treated surgically and 2 conservatively (Table 1).
Vascular complications developed after 14 (1.4%) trans-
plants: 6 (0.6%) renal artery thromboses, 3 (0.3%) venous
thromboses, 2 artery aneurysms, 1 arterial stenosis, 1 arte-
rial kinking, and 1 arterial dissection. All patients were
reoperated.
The lymphoceles that occurred in 26 (2.6%) patients
were mostly treated conservatively, with only 6 cases requir-
ing surgical drainage. There were 50 (5.0%) wound-related
complications: 32 wound hematomas and 18 wound infec-
tions.
Overall, seven (0.7%) grafts were lost, all due to vascular
complications (5 to arterial thrombosis and 2 to venous
thrombosis), despite early surgery. One patient died of
septicemia after a urinary obstruction. The actuarial graft
survival rates at 1, 3, 5, 10, and 15 years are 92%, 86%, 78%,
60%, and 50%, respectively.
DISCUSSION
Renal graft survival is directly related to recipient and
donor selection, protocols of immunosuppression, surgical
technique, and management of complications.5 Surgical
complications have become relatively infrequent; they
rarely lead to graft loss or death, and are usually technical.3
The frequency of surgical complications in our study is
within the range of other series. These complications have
traditionally been managed by open surgical correction,
although there is an increasing tendency to apply minimal
invasive techniques.4,5
Urological complications are the most common post-
transplant problems, with contemporary incidence rates
from 4% to 13%.6–8 This complication began to decrease
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Table 1. Management of Ureteral Complications
Complication Number Management
Obstruction
12 Ureteropyelostomy
11 Ureteroneocystostomy
4 Endoscopic incision
4 Temporary stenting
Fistulae
10 Ureteroureterostomy
9 Ureteroneocystostomy
4 Ureteropyelostomy
2 Temporary stenting
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with the introduction of low-dose steroid protocols. The
surgical technique and the vascularity of the donor ureter
are the main causes of urological complications, although
the contribution of rejection has yet to be clarified.6 The
technique of ureteroneocystotomy does not seem to influ-
ence the incidence of these complications.9 In our series the
primary treatment option remained an open operation.
Vascular complications, despite being rare (1.4%), have
devastating consequences, particularly arterial and venous
thrombosis, with seven graft losses despite immediate sur-
gical exploration. There has been a decreasing incidence of
lymphoceles due to minimal vessel dissection and proper
drainage. Good patient selection and a perfect technique
are the best ways to prevent surgical complications. Regular
follow-up with early diagnosis and management can decrease the
morbidity and mortality associated with these complications.
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